Document Type : Original Article


1 Department of Clinical Psychology, College of Health and Rehabilitation, Princess Nourah Abdulrahman University, Riyadh, Saudi Arabia

2 Department of Social and Preventive Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India

3 Department of Respiratory Medicine, Government Medical College, Srinagar, Jammu and Kashmir, India


BACKGROUND: The coronavirus disease‑19 (COVID‑19) emerged from China and rapidly spread
to many other countries all over the world. This study aimed to assess the prevalence of anxiety,
depression, posttraumatic stress disorder, and obsessive–compulsive (OC) symptoms among
COVID‑19 survivors after their discharge from the COVID‑19 treatment center.
MATERIALS AND METHODS: This was a cross‑sectional, hospital‑based study performed among
119 COVID‑19 survivors. The Hospital Anxiety and Depression Scale (HADS) was used to measure
anxiety and depression. Posttraumatic Stress Disorder (PTSD)‑Checklist (PCL) and Brief OC Scale
were used to measure PTSD and OC symptoms. Data were analyzed by descriptive and inferential
statistics using the SPSS (IBM Corp. Released 2015 version 23.0).
RESULTS: The mean anxiety, depression, and PTSD scores were, 7.12 ± 0.68, 8.08 ± 0.22, and
19.78 ± 0.88, respectively. Based on cutoff scores, the prevalence of anxiety, depression, and
PTSD among COVID‑19 survivors was n = 53, 44.54%; n = 73, 61.34%; and n = 30, 25.21%,
respectively. Older COVID‑19 survivors (≥50 years) were more likely to show symptoms of
depression and anxiety (P < 0.001) compared to younger ones. Furthermore, COVID‑19 survivors
who were ≥50 years of age experienced a greater level of PTSD compared to younger ones; similar
trends were seen in those experiencing OC symptoms. In the present study, n = 98 (82.4%) were
obsessed with fears of contamination and an equal number had compulsive handwashing.
CONCLUSION: Anxiety, depression, PTSD, and OC symptoms are common among the COVID‑19
survivors and that underscores the need to diagnose and manage mental health morbidities among
these survivors long after their recovery from COVID‑19.


  1. Shigemura J, Ursano RJ, Morganstein JC, Kurosawa M,
    BenedekDM. Public responses to the novel 2019 coronavirus (2019‐
    nCoV) in Japan: Mental health consequences and target
    populations. Psychiatry and clinical neurosciences. 2020 Apr;
    74 (4):281.
    2. Park HY, Jung J, Park HY, Lee SH, Kim ES, Kim HB, Song KH.
    Psychological Consequences of Survivors of COVID‑19
    Pneumonia 1 Month after Discharge. Journal of Korean medical
    science. 2020 Dec 7;35 (47).
    3. Park HY, Park WB, Lee SH, Kim JL, Lee JJ, Lee H, Shin HS.
    Posttraumatic stress disorder and depression of survivors 12
    months after the outbreak of Middle East respiratory syndrome
    in South Korea. BMC public health. 2020 Dec; 20:1‑9.
    4. Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P,
    Fusar‑Poli P, Zandi MS, Lewis G, David AS. Psychiatric
    and neuropsychiatric presentations associated with severe
    coronavirus infections: A systematic review and meta‑analysis
    with comparison to the COVID‑19 pandemic. The Lancet
    Psychiatry. 2020 Jul 1;7 (7):611‑27.
    5. Miao XR, Chen QB, Wei K, Tao KM, Lu ZJ. Posttraumatic
    stress disorder: From diagnosis to prevention. Military Medical
    Research. 2018 Dec; 5 (1):1‑7.
    6. Kucharski AJ, Russell TW, Diamond C, Liu Y, Edmunds J, Funk S,
    et al. Early dynamics of transmission and control of COVID‑19:
    A mathematical modelling study. Lancet Infect Dis 2020;20:553‑8.
    7. Torales J, O’Higgins M, Castaldelli‑Maia JM, Ventriglio A. The
    outbreak of COVID‑19 coronavirus and its impact on global
    mental health. Int J Soc Psychiatry 2020;66:317‑20.
    8. Liu CH, Zhang E, Wong GT, Hyun S. Factors associated with
    depression, anxiety, and PTSD symptomatology during the
    COVID‑19 pandemic: Clinical implications for US young adult
    mental health. Psychiatry research. 2020 Aug 1;290:113172. 20200.113172
    9. Sun L, Sun Z, Wu L, Zhu Z, Zhang F, Shang Z, Jia Y, Gu J, Zhou Y,
    Wang Y, Liu N. Prevalence and risk factors of acute posttraumatic
    stress symptoms during the COVID‑19 outbreak in Wuhan, China.
    MedRxiv. 2020 Jan 1.
    10. Fekih‑Romdhane F, Ghrissi F, Abbassi B, Cherif W, Cheour M.
    Prevalence and predictors of PTSD during the COVID‑19
    pandemic: Findings from a Tunisian community sample.
    Psychiatry Research. 2020 Aug; 290:113131. https://doi.
    org/10.1016/j.psychres. 2020.113131
    11. ForteG, Favieri F, TambelliR, CasagrandeM. COVID‑19 pandemic
    in the Italian population: Validation of a post‑traumatic stress
    disorder questionnaire and prevalence of PTSD symptomatology.
    International journal of environmental research and public health.
    2020 Jan; 17 (11):4151.
    12. Xiang YT, Yang Y, Li W, Zhang L, Zhang Q, Cheung T, et al.
    Timely mental health care for the 2019 novel coronavirus outbreak
    is urgently needed. Lancet Psychiatry 2020;7:228‑9.
    13. Brooks SK, Webster RK, Smith LE, Woodland L, Wessely S,
    Greenberg N, et al. The psychological impact of quarantine and
    how to reduce it: Rapid review of the evidence. The lancet. 2020
    Mar 14;395 (10227):912‑20.
    14. Greenberg N, Docherty M, Gnanapragasam S, Wessely S.
    Managing mental health challenges faced by healthcare workers
    during covid‑19 pandemic. bmj. 2020 Mar 26;368. https://doi.
    15. Asmundson GJ, Taylor S. Coronaphobia: Fear and the 2019‑nCoV
    outbreak. Journal of anxiety disorders. 2020 Mar; 70:102196.
    10.1016/j.janxdis. 2020.102196
    16. Li S, Wang Y, Xue J, Zhao N, Zhu T. The impact of COVID‑19
    epidemic declaration on psychological consequences: A study
    on active Weibo users. International journal of environmental
    research and public health. 2020 Jan; 17 (6):2032. https://doi.
    17. Rosso G, Albert U, Asinari GF, Bogetto F, Maina G. Stressful
    life events and obsessive–compulsive disorder: Clinical
    features and symptom dimensions. Psychiatry research. 2012
    May 30;197 (3):259‑64.
    18. World Health Organization ( W H O ) . N o v e l
    Coronavirus (2019‑nCoV) Situation Reports; 2020. Available
    novel‑coronavirus‑2019/situation‑reports. [Last accessed on
    2020 Jun 09].
    19. Djukanovic I, Carlsson J, Årestedt K. Is the Hospital Anxiety and
    Depression Scale (HADS) a valid measure in a general population
    65‑80 years old? A psychometric evaluation study. Health Qual
    Life Outcomes 2017;15:193.
    20. Rishi P, Rishi E, Maitray A, Agarwal A, Nair S, Gopalakrishnan S.
    Hospital anxiety and depression scale assessment of 100 patients
    before and after using low vision care: A prospective study in a
    tertiary eye‑care setting. Indian J Ophthalmol 2017;65:1203.
    21. Bah AJ, James PB, Bah N, Sesay AB, Sevalie S, Kanu JS. Prevalence
    of anxiety, depression and post‑traumatic stress disorder among
    Ebola survivors in northern Sierra Leone: A cross‑sectional study.
    BMC Public Health 2020;20:1391.
    22. Turon H, Carey M, Boyes A, Hobden B, Dilworth S,
    Sanson‑Fisher R. Agreement between a single‑item measure of
    anxiety and depression and the Hospital Anxiety and Depression
    Scale: A cross‑sectional study. PLoS One 2019;14:e0210111.
    23. Luceño‑Moreno L, Talavera‑Velasco B, García‑Albuerne Y,
    Martín‑García J. Symptoms of posttraumatic stress, anxiety,
    depression, levels of resilience and burnout in Spanish health
    personnel during the COVID‑19 pandemic. Int J Environ Res
    Public Health 2020;17:5514.
    24. Waterman S, Hunter EC, Cole CL, Evans LJ, Greenberg N,
    Rubin GJ, et al. Training peers to treat Ebola centre workers
    with anxiety and depression in Sierra Leone. Int J Soc Psychiatry
    25. Blevins CA, Weathers FW, Davis MT, Witte T, Domino JL. The
    posttraumatic stress disorder checklist for DSM‑5 (PCL‑5):
    Development and Initial Psychometric Evaluation. J Trauma
    Stress 2015;28:489‑98.
    26. Ibrahim H, Ertl V, Catani C, Ismail AA, Neuner F. The validity
    of posttraumatic stress disorder checklist for DSM‑5 (PCL‑5)
    as screening instrument with Kurdish and Arab displaced
    populations living in the Kurdistan region of Iraq. BMC Psychiatry
    27. Bejerot S, Edman G, Anckarsäter H, Berglund G, Gillberg C,
    Hofvander B, et al. The Brief Obsessive‑Compulsive Scale (BOCS):
    A self‑report scale for OCD and obsessive‑compulsive related
    disorders. Nord J Psychiatry 2014;68:549‑59.
    28. Bohmwald K, Gálvez NM, Ríos M, Kalergis AM. Neurologic
    alterations due to respiratory virus infections. Front Cell Neurosci
    29. de Medeiros Carvalho PM, Moreira MM, de Oliveira MN,
    Landim JM, Neto ML. The psychiatric impact of the novel
    coronavirus outbreak. Psychiatry research. 2020 Apr; 286:112902. 20200.112902
    30. Kong X, Zheng K, Tang M, Kong F, Zhou J, Diao L, Wu S, Jiao P,
    Su T, Dong Y. Prevalence and factors associated with depression
    and anxiety of hospitalized patients with COVID‑19. MedRxiv.
  2. 2020 Jan 1.
    31. Li X, Tian J, Xu Q. The Associated Factors of Anxiety and
    Depressive Symptoms in COVID‑19 Patients Hospitalized in
    Wuhan, China. Psychiatric Quarterly. 2020 Nov 23:1‑9. https://‑020‑09865‑9
    32. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous
    system involvement after infection with COVID‑19 and other
    coronaviruses. Brain Behav Immun 2020;87:18‑22.
    33. Zheng Y, Xiao L, Xie Y, Wang H, Wang G. Prevalence and
    Characteristics of Obsessive‑Compulsive Disorder Among Urban
    Residents in Wuhan During the Stage of Regular Control of
    Coronavirus Disease‑19 Epidemic. Frontiers in psychiatry. 2020
    Dec 16;11:1435.
    34. Zamanian M, Ahmadi D, Sindarreh S, Aleebrahim F,
    Vardanjani HM, Faghihi SH, et al. Fear and rumor associated
    with COVID‑19 among Iranian adults, 2020. J Educ Health Promot
    35. Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I,
    et al. Anxiety and depression in COVID‑19 survivors: Role
    of inflammatory and clinical predictors. Brain Behav Immun
    36. Zhang J, Lu H, Zeng H, Zhang S, Du Q, Jiang T, et al. The
    differential psychological distress of populations affected by the
    COVID‑19 pandemic. Brain Behav Immun 2020;87:49‑50.
    37. Pietrzak RH, Tracy M, Galea S, Kilpatrick DG, Ruggiero KJ,
    Hamblen JL, et al. Resilience in the face of disaster: Prevalence
    and longitudinal course of mental disorders following hurricane
    Ike. PLoS One 2012;7:e38964.
    38. Makwana N. Disaster and its impact on mental health: A narrative
    review. J Family Med Prim Care 2019;8:3090‑5.
    39. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R.
    Features, evaluation and treatment coronavirus (COVID‑19).
    Statpearls [internet]. 2020 Mar 8.
    40. Qu YM, Kang EM, Cong HY. Positive result of Sars‑Cov‑2 in
    sputum from a cured patient with COVID‑19. Travel medicine
    and infectious disease. 2020 Mar 1. 10.1016/j.tmaid. 2020.101619
    41. Chen D, Xu W, Lei Z, Huang Z, Liu J, Gao Z, et al. Recurrence
    of positive SARS‑CoV‑2 RNA in COVID‑19: A case report. Int J
    Infect Dis 2020;93:297‑9.
    42. Ni MY, Yao XI, Leung KS, Yau C, Leung CM, Lun P, et al.
    Depression and post‑traumatic stress during major social unrest
    in Hong Kong: A 10‑year prospective cohort study. Lancet
    43. Achdut N, Refaeli T. Unemployment and psychological
    distress among young people during the COVID‑19 pandemic:
    Psychological resources and risk factors. Int J Environ Res Public
    Health 2020;17:7163.
    44. Chang MC, Park D. Incidence of post‑traumatic stress disorder
    after coronavirus disease. Healthcare (Basel) 2020;8:373.
    45. Mowbray H. In Beijing, coronavirus 2019‑nCOV has created a
    siege mentality. BMJ 2020;368:m516.
    46. Xiao S, Luo D, Xiao Y. Survivors of COVID‑19 are at high risk of
    posttraumatic stress disorder. Glob Health Res Policy 2020;5:29.
    47. Fontenelle LF, Cocchi L, Harrison BJ, Miguel EC, Torres AR. Role
    of stressful and traumatic life events in obsessive‑compulsive
    disorder. Neuropsychiatry 2011;1:61.
    48. Abba‑Aji A, Li D, Hrabok M, Shalaby R, Gusnowski A,
    Vuong W, et al. COVID‑19 pandemic and mental health:
    prevalence and correlates of new‑onset obsessive‑compulsive
    symptoms in a Canadian province. Int J Environ Res Public
    Health 2020;17:6986.
    49. Subramaniam M, Abdin E, VaingankarJA, Chong SA. Obsessive–
    compulsive disorder: Prevalence, correlates, help‑seeking and
    quality of life in a multiracial Asian population. Soc Psychiatry
    Psychiatr Epidemiol 2012;47:2035‑43.
    50. Brakoulias V, Starcevic V, Belloch A, Brown C, Ferrao YA,
    Fontenelle LF, et al. Comorbidity, age of onset and suicidality
    in obsessive‑compulsive disorder (OCD): An international
    collaboration. Compr Psychiatry 2017;76:79‑86.
    51. Anholt GE, Aderka IM, Van Balkom AJ, Smit JH, Schruers K,
    Van Der Wee NJ, et al. Age of onset in obsessive–compulsive
    disorder: Admixture analysis with a large sample. Psychol Med
    52. Wang Y, Di Y, Ye J, Wei W. Study on the public psychological
    states and its related factors during the outbreak of coronavirus
    disease 2019 (COVID‑19) in some regions of China. Psychology,
    health & medicine. 2021 Jan 2;26 (1):13‑22.
    53. Papaioannou AI, Bartziokas K, Tsikrika S, Karakontaki F,
    Kastanakis E, Banya W, et al. The impact of depressive symptoms
    on recovery and outcome of hospitalized COPD exacerbations.
    Eur Respir J 2013;41:815‑23.